Idiopathisches Parkinson-Syndrom (IPS) | SpringerLink
Schematic representation of dyskinesias occurring in relation with a... | Download Scientific Diagram
Mean dyskinesia scores T SD in patients in the levodopa and lisuride... | Download Scientific Diagram
Prevalence and risk factor of peak-dose dyskinesia in Thai patients with Parkinson's disease - MDS Abstracts
Levodopa-induzierte Dyskinesien bei Morbus Parkinson | SpringerLink
Relationship between LID and DOPA plasma level. “Peak of dose” or “on”... | Download Scientific Diagram
Therapie des idiopathischen Parkinson-Syndroms
Medikamentöse Therapien in der Spätphase des Morbus Parkinson - Neurologie - Universimed - Medizin im Fokus
Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease | Neurology
Medikamentöse Therapie - Deutsche Parkinson Vereinigung e.V.
Ataxic Disorders | Basicmedical Key
wearing off 145
11 Bewegungsstörungen
Medikamentöse Therapie der Parkinson-Krankheit: Eine interdisziplinäre Aufgabe
Prevalence and risk factor of peak-dose dyskinesia in Thai patients with Parkinson's disease - MDS Abstracts
Cells | Special Issue : Dyskinesia in Parkinson's Disease: New Mechanisms and Molecular Targets
Klinische Prüfung der oralen Lisurid-Therapie bei Morbus Parkinson
Hypokinetische Erkrankungen (Hypokinesien) Flashcards | Quizlet
2.3 Therapie
Prevalence and risk factor of peak-dose dyskinesia in Thai patients with Parkinson's disease - MDS Abstracts
The Need for Enhanced Strategies to Manage Levodopa-Induced Dyskinesia in Parkinson's Disease
Mean dyskinesia scores T SD in patients in the levodopa and lisuride... | Download Scientific Diagram
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - The Lancet Neurology
